Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Gastroenterology|May 1, 1990
Effect of loxiglumide on gallbladder contractile response to cerulein and food in humansA Malesci, C De Fazio, S Festorazzi, et al.
Arzneimittel-Forschung|January 1, 1979
Pharmacological study of a new non-steroidal anti-inflammatory drug: protacine (CR 604)A L Rovati, R R Vidal y Plana, P L Casula, et al.
Minerva Medica|January 14, 1982
[The natural development of arteriosclerotic coronary disease. Coronarographic study in time intervals]F Passoni, M D'Urbano, L Aiazzi, et al.
Giornale Italiano Di Cardiologia|January 1, 1981
[Aortic valve disease and coronary atherosclerosis. Clinical and coronarographic study (author's transl)]F Passoni, M D'Urbano, L Aiazzi, et al.
Peptides|November 1, 1986
Protective effect of CR 1409 (cholecystokinin antagonist) on experimental pancreatitis in rats and miceF Makovec, M Bani, R Cereda, et al.
Minerva Medica|March 10, 1983
[Fixed subvalvular aortic stenosis. Monodimensional echocardiographic findings]M D'Urbano, G F Sbarbaro, G Seveso, et al.
The American Journal of Physiology|December 1, 1986
Structural features of various proglumide-related cholecystokinin receptor antagonistsR T Jensen, Z C Zhou, R B Murphy, et al.
Arzneimittel-Forschung|June 1, 1987
Pharmacological characterisation of a new potent and specific nonpolypeptidic cholecystokinin antagonistI Setnikar, M Bani, R Cereda, et al.
Arzneimittel-Forschung|November 1, 1987
Pharmacological properties of lorglumide as a member of a new class of cholecystokinin antagonistsF Makovec, M Bani, R Cereda, et al.
The Journal of Clinical Investigation|March 1, 1990
Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in manP Hildebrand, C Beglinger, K Gyr, et al.
Pageof 8